Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Artemisia leaf-containing pharmaceutical composition for treating community-acquired pneumonia

A technology of acquired pneumonia and composition, which is applied in the direction of drug combination, medical preparations containing active ingredients, and pharmaceutical formulas. The effect of short, simple and easy preparation process

Inactive Publication Date: 2016-06-22
GUANGZHOU SANDE MEDICAL TECH CO LTD
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] There are many invention patents for the treatment of community-acquired pneumonia published at present, for example: Chinese invention patent application: 201410822536.1 discloses the use of a pharmaceutical composition in the preparation of medicines for the treatment of community-acquired pneumonia, the pharmaceutical composition includes Radix Pseudostellariae, Radix Astragali , Ophiopogon japonicus, Polygonatum odoratum, Palm ginseng, Rehmannia glutinosa, Trichosanthum pollen, Scutellaria baicalensis, Hedyotis diffusa, and licorice, but the existing pharmaceutical compositions have relatively single applicability, long course of treatment, and no obvious effect

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Artemisia leaf-containing pharmaceutical composition for treating community-acquired pneumonia
  • Artemisia leaf-containing pharmaceutical composition for treating community-acquired pneumonia
  • Artemisia leaf-containing pharmaceutical composition for treating community-acquired pneumonia

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0043] The pharmaceutical composition of Example 1 of the present invention is prepared from the following raw materials in parts by weight:

[0044] 20 parts of mugwort leaves, 18 parts of Scutellaria baicalensis, 15 parts of cotyledon leaves, 17 parts of Chuan Fritillaria, 16 parts of radish seeds, 15 parts of Radix Ginseng

[0045] 17 parts of blue stone grass 12 parts of Ophiopogon 12 parts of citron 14 parts of dendrobium 13 parts of Tianzhuhuang 10 parts of licorice 6 parts

[0046] The preparation method is as follows:

[0047] (1) remove impurities from Artemisia argyi, Scutellaria baicalensis, cotyledon, Chuan Fritillaria, Radish Seed, and Licorice, wash, dry, and pulverize into coarse powder;

[0048] (2) removing the surface layer of the sand ginseng, washing, drying, and pulverizing into coarse powder;

[0049] (3) Mix the coarse powder prepared in the above step (1) and step (2) evenly, add 6 times the total weight of the coarse powder, soak in water for 1 hour,...

Embodiment 2

[0054] The pharmaceutical composition of Example 2 of the present invention is prepared from the following raw materials in parts by weight:

[0055] 27 parts of mugwort leaves, 26 parts of Scutellaria baicalensis, 21 parts of cotyledon leaves, 22 parts of Chuan Fritillaria, 21 parts of radish seeds, 20 parts of Radix Ginseng

[0056] Lanshicao 22 parts Ophiopogon 18 parts Citron 19 parts Dendrobium 19 parts Tianzhuhuang 17 parts Licorice 13 parts

[0057] The preparation method is as follows:

[0058] (1) remove impurities from Artemisia argyi, Scutellaria baicalensis, cotyledon, Chuan Fritillaria, Radish Seed, and Licorice, wash, dry, and pulverize into coarse powder;

[0059] (2) removing the surface layer of the sand ginseng, washing, drying, and pulverizing into coarse powder;

[0060] (3) Mix the coarse powder prepared in the above step (1) and step (2) evenly, add 12 times the total weight of the coarse powder, soak in water for 3 hours, and decoct for 5 hours; filter...

Embodiment 3

[0065] The pharmaceutical composition of Example 3 of the present invention is prepared from the following raw materials in parts by weight:

[0066] 24 parts of mugwort leaves, 22 parts of Scutellaria baicalensis, 18 parts of cotyledon leaves, 24 parts of Chuan Fritillaria, 19 parts of radish seeds, 18 parts of Radix Ginseng

[0067] 19 parts of blue stone grass 15 parts of Ophiopogon 15 parts of citron 17 parts of dendrobium 16 parts of Tianzhuhuang 14 parts of licorice 10 parts

[0068] The preparation method is as follows:

[0069] (1) remove impurities from Artemisia argyi, Scutellaria baicalensis, cotyledon, Chuan Fritillaria, Radish Seed, and Licorice, wash, dry, and pulverize into coarse powder;

[0070] (2) removing the surface layer of the sand ginseng, washing, drying, and pulverizing into coarse powder;

[0071] (3) Mix the coarse powder prepared in the above step (1) and step (2) evenly, add 12 times the total weight of the coarse powder, soak in water for 3 hou...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the technical field of traditional Chinese medicines and relates to an artemisia leaf-containing pharmaceutical composition for treating community-acquired pneumonia. The pharmaceutical composition is prepared from the artemisia leaves, radix scutellariae, elaeagnus pungens leaves, Sichuan fritillary bulb, radish seeds, radix adenophorae, lancea tibetica, radix ophiopogonis, citrus medica, dendrobium nobile, concretio silicea and glycyrrhiza uralensis. The pharmaceutical composition complies with the prescription rule of monarch, minister, adjuvant and conductant, is appropriate in medication, strict in compatibility and clear between primary and secondary, gains mutually and can be used for relieving asthma and cough, clearing heat and moistening lung and invigorating Qi and strengthening body resistance. During the treatment of the community-acquired pneumonia, the pharmaceutical composition is high in pertinence, obvious in treatment effect and high in cure rate.

Description

technical field [0001] The invention belongs to the technical field of traditional Chinese medicines, and in particular relates to a medicinal composition containing mugwort leaves for treating community-acquired pneumonia. Background technique [0002] Community-acquired pneumonia refers to infectious lung parenchyma (including alveolar wall, that is, pulmonary interstitium in a broad sense) inflammation that is induced outside the hospital, including pneumonia with a clear incubation period of pathogen infection that occurs during the incubation period after admission to the hospital. CAP is one of the common infectious diseases that threaten human health. The composition and drug resistance characteristics of its pathogens are significantly different in different countries and regions, and they are constantly changing over time. [0003] In recent years, due to the aging of the social population, the increase of immune compromised hosts, the change of pathogens, and the i...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/899A61P11/00
CPCA61K36/282A61K36/185A61K36/23A61K36/31A61K36/34A61K36/342A61K36/484A61K36/539A61K36/752A61K36/80A61K36/8966A61K36/8968A61K36/8984A61K36/899A61K2236/15A61K2236/331A61K2236/333A61K2236/39A61K2236/51A61K2300/00
Inventor 王一飞吴国宪王亦梁
Owner GUANGZHOU SANDE MEDICAL TECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com